Note 3 - Acquisitions of Ownership Interests	6 Months Ended
Jun. 30, 2021
Notes to Financial Statements
Equity Method and Other Investments Disclosure [Text Block]	3. Acquisitions of Ownership Interests The following is a summary of additional deployments during the six month period ended June 30, 2021: During the six months ended June 30, 2021, Syapse raised $68 million of preferred equity which reduced the Company's ownership interest to approximately 11%. The Company recorded a $7.3 million dilution gain as a result of this transaction, which is included in Equity income (loss), net in the Consolidated Statements of Operation. Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models. During the six months ended June 30, 2021, the Company funded an additional $1.0 million of convertible loans to Trice Medical, Inc. The Company had previously deployed an aggregate of $10.8 million. Trice is focused on orthopedic diagnostics using fully integrated camera-enabled technologies to provide clinical solutions to physicians.

Note 3 - Acquisitions of Ownership Interests

6 Months Ended

Jun. 30, 2021

Equity Method and Other Investments Disclosure [Text Block]

3. Acquisitions of Ownership Interests

The following is a summary of additional deployments during the six month period ended June 30, 2021:

During the six months ended June 30, 2021, Syapse raised $68 million of preferred equity which reduced the Company's ownership interest to approximately 11%. The Company recorded a $7.3 million dilution gain as a result of this transaction, which is included in Equity income (loss), net in the Consolidated Statements of Operation. Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models.

During the six months ended June 30, 2021, the Company funded an additional $1.0 million of convertible loans to Trice Medical, Inc. The Company had previously deployed an aggregate of $10.8 million. Trice is focused on orthopedic diagnostics using fully integrated camera-enabled technologies to provide clinical solutions to physicians.